Over the 50 years since UnitedHealth was founded, Richard T. Burke (81) has given few interviews. Now he has given an exclusive interview to "Globes", during what is perhaps the most turbulent period ...
Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...
The integration of Clinical Data Studio into ICON's service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...
2d
New Scientist on MSNWhat is vibe coding, should you be doing it, and does it matter?The rise of large language models like ChatGPT that can churn out computer code has led to a new term - vibe coding - for ...
IKS Health, a global leader in care enablement solutions supporting clinicians and patients at every step of the care journey, is proud to announce two new 2025 Black Book Research leadership wins: ...
The integration of Clinical Data Studio into ICON’s service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...
“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations ...
“IKS Health’s recent successes in Clinical Documentation and Coding, along with securing the top spot in our inaugural AI-driven Revenue Cycle Management category, highlight their continued ...
8d
Clinical Trials Arena on MSNIcon integrates Medidata’s Clinical Data Studio into clinical studiesIcon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...
Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...
Mr. Banko’s appointment along with the Company’s recent developments supports the previously announced topline forecast of $1 billion in launch year for Tevogen Bio Oncology and nearly $1 billion for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results